SAG
INBX icon

SageView Advisory Group’s Inhibrx INBX Stock Holding History

SageView Advisory Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.21K Buy
+28
New +$1.91K ﹤0.01% 2215

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SageView Advisory Group's INBX Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Inhibrx (INBX) in Q4 2025: 28 shares worth $2.21K. The stake represents ﹤0.01% of the portfolio and ranks #2215 among its holdings.

138 funds tracked by Wall St. Rank hold INBX as of Q4 2025.

  • SageView Advisory Group held 28 shares of Inhibrx worth $2.21K as of Q4 2025.
  • Inhibrx was a new SageView Advisory Group position in Q4 2025.
  • Inhibrx made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2215 holding.
  • 138 funds tracked by Wall St. Rank held Inhibrx as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.